Wird geladen...
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
Novel drugs have revolutionized multiple myeloma therapy in the last 20 years, with median survival that has doubled to up to 8–10 years. The introduction of therapeutic strategies, such as consolidation and maintenance after autologous stem cell transplants, has also ameliorated clinical results. T...
Gespeichert in:
| Veröffentlicht in: | J Pers Med |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565263/ https://ncbi.nlm.nih.gov/pubmed/32927719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm10030120 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|